NIH Health Research

A weekly summary of research developments and discoveries at the National Institutes of Health (NIH)
  1. A study found that biological risk factors—including weight and fat around the abdomen—are primarily responsible for the elevated rate of diabetes for black Americans.
  2. A comprehensive analysis found that even short-term exposures to air pollution may have an impact on the health of older adults.
  3. Researchers developed a genome editing strategy to treat hearing loss in a mouse model of hereditary deafness.
  4. NIH accomplishments in the prevention, diagnosis, and treatment of human disease. These include progress on two Ebola vaccines, a bionic pancreas to treat type 1 diabetes, and a genetic test that improves blood thinner dosing.
  5. NIH findings with potential for enhancing human health include understanding how dietary factors influence disease risk, combatting the epigenetic effects of outdoor air pollution, and methods to detect prions in blood and skin.
  6. Noteworthy NIH advances in basic research include a 3-D model of human brain development and disease, a virus linked to food sensitivity, and a new role discovered for the thalamus.
  7. HIV prevention measures substantially reduced new HIV infections in a district of Uganda during a seven-year period. The results prove the approach can reduce new HIV infections.
  8. Researchers identified the cause of some patients’ repeated episodes of anaphylaxis: a red meat allergy that’s linked to a specific type of tick bite.
  9. A lab study may help explain on the molecular level why saturated fat can harm cells and unsaturated fat can be protective.
  10. A study of older adults with peripheral artery disease showed that treadmill exercise for 12 weeks improved walking distance, but a drug called GM-CSF did not.
  11. Researchers detected abnormal prion proteins in the skin of people who died from Creutzfeldt-Jakob disease. The results suggest that skin samples might be used to detect prion disease.
  12. A single enzyme altered the mix of bacteria in the guts of mice and led to inflammatory bowel disease. The study suggests a potential treatment target for diseases such as Crohn’s disease and ulcerative colitis.
Trial Interest Form
1000 characters left

Trial Interest Form

Find out if you may qualify to participate in the Liberty 2 Study
Do I qualify?